Visteon Corp
XMUN:VS51
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Visteon Corp
XMUN:VS51
|
US |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
CN |
|
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
US |
|
G
|
Gemfields Group Ltd
JSE:GML
|
GG |
|
AdCapital AG
F:ADC
|
DE |
|
Taskus Inc
NASDAQ:TASK
|
US |
Wall St Price Targets
VS51 Price Targets Summary
Visteon Corp
According to Wall Street analysts, the average 1-year price target for VS51 is 108.62 EUR with a low forecast of 92.41 EUR and a high forecast of 123.52 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VS51's stock price target?
Price Target
108.62
EUR
According to Wall Street analysts, the average 1-year price target for VS51 is 108.62 EUR with a low forecast of 92.41 EUR and a high forecast of 123.52 EUR.
What is the Revenue forecast for Visteon Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 5 years is 5%.
What is the Operating Income forecast for Visteon Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 5 years is 5%.
What is the Net Income forecast for Visteon Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 5 years is 10%.
